Topic: Pharmaceutical

A first-in-class antifungal that failed to become a big seller under Scynexis is getting another […]

Bicycle Therapeutics’ novel approach to developing peptide drugs has produced several cancer clinical-stage drug candidates. […]

Regeneron Pharmaceuticals already has a presence in immunology, but nothing in its portfolio or pipeline […]

Vertex Pharmaceuticals has two clinical-stage programs for type 1 diabetes, each employing different methods for […]

Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with cancer care support company OncoPower to offer […]

In its latest dive into healthcare, Amazon is launching a generic medication subscription service through its online […]

Congress passed the FDA Modernization Act 2.0 last week removing the requirement to use animal […]

PharmaJet announced today that it received a grant worth $800,000-plus from the NIH to evaluate […]

In collaboration with leading pharmaceutical companies, Becton Dickinson has introduced a next-generation glass prefillable syringe (PFS). Effivax’s […]

Spine BioPharma recently announced the first patient treated in a Phase 3 clinical study of […]

The Senate passed legislation on Thursday that would reauthorize the Food and Drug Administration’s user […]

Specialty medication prices in the U.S. are out of control. Despite making up about 2% […]

Artificial intelligence is finding its way into healthcare at an astonishing rate. A new collaboration […]

Vivera announced today that it received the third U.S. patent for its Zicoh electronic dose-controlled […]

For many people, remembering to take their medications can be a daily battle. A person’s […]

Norovirus sickens hundreds of millions of people around the world each year, sparking infection that […]

Taiwanese mobile health developer iXensor has obtained an undisclosed strategic investment from Rohto Pharmaceutical Co. […]

For the second time this year, German drugmaker Bayer has nabbed an oncology leader from […]

AbbVie is bowing out of the alpha-synuclein race. Having taken a drug candidate to the […]

Bausch + Lomb is returning to the public markets in an IPO expected to rank among the biggest in healthcare.

Thermo Fisher Scientific (NYSE:TMO) announced today that it completed its acquisition of PeproTech for approximately $1.85 […]

Xeris Biopharma (NSDQ:XERS) announced today that it entered into a securities purchase agreement in connection […]

The past year saw significant changes in the medtech space. Our editorial team picked their […]

Novo Nordisk (NYSE:NVO) announced today that its acquisition of Dicerna Pharmaceuticals (NSDQ:DRNA) has been completed. Completion of the […]

PharmaJet announced today that one of its pharmaceutical partners, Nykode Therapeutics, has begun a trial […]

Aerogen and CanSinoBio announced today that they entered a partnership to deliver the latter’s COVID-19 vaccine with Aerogen’s […]

The New Brunswick, NJ-based company is splitting off its consumer products business from the medical device and pharma units.

Pear Therapeutics today announced the publication of positive results from real-world data of its reSET-O […]

The FDA improved an Impel NeuroPharma migraine treatment, a nasal spray intended to bring pain relief more quickly than drugs administered in other ways. It marks the first approval for the Seattle company, which has developed a proprietary nasal delivery technology.

The regulatory decision clears the way for more vaccine mandates in the U.S.

MedAlliance announced today that it enrolled the first patient in an erectile dysfunction (ED) feasibility study […]

Verily’s recent moves have signaled the company’s interest in supporting decentralized clinical trials and real-world studies. Now the life sciences subsidiary of Alphabet is bolstering its capabilities in these areas with the acquisition of startup SignalPath.

Eli Lilly (NYSE:LLY) today announced executive leadership changes as it creates neuroscience and immunology business […]

Sanofi has struck a deal to buy its mRNA partner Translate Bio in a $3.2 billion deal. […]

The engineered viruses used to deliver gene therapies can spark complications and they can’t be re-dosed. Ring Therapeutics says viruses that evolved with humans can be better viral vectors and the startup has raised $117 million in new financing to continue its research.

Amgen is paying $900 million up front to acquire Teneobio, a biotech with technology for discovering and developing antibody drugs. Though Amgen already has its own antibody platform, the company says Teneobio’s technology and drug assets will complement its own.

United Therapeutics (NSDQ:UTHR) today announced positive results from an analysis of forced vital capacity (FVC) change […]

Genentech announced that the FDA accepted its Biologics License Application (BLA) for its Port Delivery […]

Cardinal Health (NYSE:CAH) announced today that the FDA approved its Lymphoseek injection for pediatric use. […]